Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1

Bup/Nx - Facilitated Rehab for Opioid Dependent Adolescents

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00078130

Enrollment

223

Registered

2004-02-20

Start date

2003-07-31

Completion date

2006-01-31

Last updated

2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid-Related Disorders

Keywords

opioid dependence, behavioral intervention

Brief summary

The purpose of this study is to compare two 3-month treatments for adolescents/young adults who are addicted to heroin: buprenorphine/naloxone combined with psychosocial therapy and treatment as usual, a 7-14 day detoxification with buprenorphine and three weeks of psychosocial therapy.

Interventions

DRUGBuprenorphine/naloxone

Study design

Primary purpose

TREATMENT

Eligibility

Sex/Gender

ALL

Age

14 Years to 21 Years

Healthy volunteers

Inclusion criteria

Male and non-pregnant female subjects seeking outpatient treatment for opioid dependence with physiological features without serious medical or psychiatric disorders.

Design outcomes

Primary

Measure	Time frame
Opiate abstinence	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026